Tenders/Pharmaceutical products
Awarded🇺🇦UkraineSuppliesThis tender has expired

Pharmaceutical products

Auto-translated from uk
Original title: «Фармацевтична продукція» (Епінефрин (адреналін) (Epinephrine), Азитроміцин (Azithromycin), Метамізол натрію (Metamizole sodium), Диклофенак (Diclofenac), Дротаверин (Drotaverine), Дротаверин (Drotaverine), Есциталопрам (Escitalopram), Ібупрофен (Ibuprofen), Кальцію глюконат (Calcium gluconate), Кветіапін (Quetiapine), Кларитроміцин (Clarithromycin), Левофлоксацин (Levofloxacin), Лідокаїн (Lidocaine), Лоратадин (Loratadine), Магнію сульфат (Magnesium sulfate), Меропенем (Meropenem), Метоклопрамі
Військово-медичний клінічний центр Центрального регіону
Published: Mar 6, 2026
Updated: Aug 8, 2026
Source: prozorro_ua

About This Opportunity

Translated

This tender is for the procurement of a range of pharmaceutical products, including but not limited to Epinephrine, Azithromycin, Metamizole sodium, Diclofenac, Drotaverine, Escitalopram, Ibuprofen, Calcium gluconate, Quetiapine, Clarithromycin, Levofloxacin, Lidocaine, Loratadine, Magnesium sulfate, Meropenem, and Metoclopramide. A key condition is that the goods must have at least 70% of their shelf life remaining at the time of delivery, as determined by the manufacturer. Deliveries will be made based on the customer's requests. Furthermore, the country of origin for the goods cannot be the Russian Federation, the Republic of Belarus, or the Islamic Republic of Iran. The tender specifies Meropenem, powder for injection/infusion, 1g, and lists other items such as Epinephrine solution for injection, Azithromycin tablets/capsules, and Metamizole sodium solution for injection. This comprehensive procurement aims to ensure the availability of essential medicines for a healthcare provider, with strict requirements on product quality, shelf life, and origin to comply with national regulations and policies.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 4.0 million.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Auto-translated from uk

The goods must be shipped by the Supplier in such a way that at the time of delivery, at least 70% of their total shelf life, determined by the manufacturer, remains; delivery is based on the Customer's request.

The country of origin of the goods cannot be the Russian Federation/Republic of Belarus/Islamic Republic of Iran.

Meropenem, powder for injection/infusion, 1 g

Items: Epinephrine 1.82 mg/ml, solution for injection, ampoule (Medicinal products for the treatment of blood diseases, hematopoietic organs and cardiovascular system diseases) [CPV: 33620000-2]; Azithromycin tablets/capsules 500 mg (General anti-infective agents for systemic use, vaccines, antineoplastic and immunomodulatory drugs) [CPV: 33650000-1]; Metamizole sodium, solution for injection, 500 mg/ml, 2 ml (Medicinal products for the treatment of nervous system diseases and sensory organ diseases) [CPV: 33660000-4]; Diclofenac solution for injection 25 mg/ml (Medicinal products for the treatment of dermatological diseases and musculoskeletal system diseases) [CPV: 33630000-5]; Drotaverine solution for injection 20 mg/ml, 2 ml in an ampoule (Medicinal products for the treatment of gastrointestinal diseases and metabolic disorders) [CPV: 33610000-9]; Drotaverine tablets 40 mg (Medicinal products for the treatment of gastrointestinal diseases and metabolic disorders) [CPV: 33610000-9]; Escitalopram, tablets, 10 mg (Medicinal products for the treatment of nervous system diseases and sensory organ diseases) [CPV: 33660000-4]; Ibuprofen tablets/capsules 200 mg (Medicinal products for the treatment of dermatological diseases and musculoskeletal system diseases) [CPV: 33630000-5]; Calcium gluconate solution for injection 100 mg/ml, 10 ml (Medicinal products for the treatment of gastrointestinal diseases and metabolic disorders) [CPV: 33610000-9]; Quetiapine, film-coated tablets, 25 mg (Medicinal products for the treatment of nervous system diseases and sensory organ diseases) [CPV: 33660000-4]; Clarithromycin tablets, film-coated, 500 mg (General anti-infective agents for systemic use, vaccines, antineoplastic and immunomodulatory drugs) [CPV: 33650000-1]; Levofloxacin, tablets 500 mg (General anti-infective agents for systemic use, vaccines, antineoplastic and immunomodulatory drugs) [CPV: 33650000-1]; Lidocaine, solution for injection, 20 mg/ml, 2 ml (Medicinal products for the treatment of nervous system diseases and sensory organ diseases) [CPV: 33660000-4]; Loratadine tablets 10 mg (Medicinal products for the treatment of respiratory system diseases) [CPV: 33670000-7]; Magnesium sulfate, solution for injection, 250 mg/ml, 5 ml (Medicinal products for the treatment of blood diseases, hematopoietic organs and cardiovascular system diseases) [CPV: 33620000-2]; Meropenem, powder for injection/infusion, 1 g (General anti-infective agents for systemic use, vaccines, antineoplastic and immunomodulatory drugs) [CPV: 33650000-1]; Metoclopramide, tablets, 10 mg (Medicinal products for the treatment of gastrointestinal diseases and metabolic disorders) [CPV: 33610000-9]; Sodium thiosulfate solution for injection 300 mg/ml 5 ml (Miscellaneous medicinal products) [CPV: 33690000-3]; Omeprazole 40 mg vial (Medicinal products for the treatment of gastrointestinal diseases and metabolic disorders) [CPV: 33610000-9]; Omeprazole capsules 20 mg (Medicinal products for the treatment of gastrointestinal diseases and metabolic disorders) [CPV: 33610000-9]; Paracetamol tablets/capsules 500 mg (Medicinal products for the treatment of dermatological diseases and musculoskeletal system diseases) [CPV: 33630000-5]; Xylometazoline nasal spray, 1 mg/ml, 10 ml (Medicinal products for the treatment of respiratory system diseases) [CPV: 33670000-7]; Furosemide, solution for injection, 10 mg/ml, 2 ml (Medicinal products for the treatment of blood diseases, hematopoietic organs and cardiovascular system diseases) [CPV: 33620000-2]; Cefazolin, powder for injection 1 g (General anti-infective agents for systemic use, vaccines, antineoplastic and immunomodulatory drugs) [CPV: 33650000-1]; Ceftriaxone, powder for injection 1 g (General anti-infective agents for systemic use, vaccines, antineoplastic and immunomodulatory drugs) [CPV: 33650000-1]; Miconazole cream/gel 20 mg/g, 15 g (Medicinal products for the treatment of dermatological diseases and musculoskeletal system diseases) [CPV: 33630000-5]

Procuring entity: Military Medical Clinical Center of the Central Region

Data provenance

This notice is sourced from ProZorro Ukraine and was originally published on March 6, 2026. Last refreshed 4 days ago. Original language: uk. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Військово-медичний клінічний центр Центрального регіону

Військово-медичний клінічний центр Центрального регіону has issued 156 procurement notices on BidsFactory, including 2 currently open and 56 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Construction & Civil Works. All notices are published for Ukraine. Notices are distributed via ProZorro Ukraine. Most recent publication: August 11, 2026.

Frequently asked questions about this tender

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

How much was the contract awarded for?

ПРИВАТНЕ АКЦІОНЕРНЕ ТОВАРИСТВО "ФАРМАЦЕВТИЧНА ФІРМА "ДАРНИЦЯ" was awarded the contract for UAH 4,023,992. The figure reflects the value disclosed by the contracting authority in the award notice.

Where will the contract be performed?

The contract is for delivery in Ukraine. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit ProZorro Ukraine to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to ПРИВАТНЕ АКЦІОНЕРНЕ ТОВАРИСТВО "ФАРМАЦЕВТИЧНА ФІРМА "ДАРНИЦЯ". The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by Військово-медичний клінічний центр Центрального регіону in Ukraine. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

Find tenders like this automatically

Set up alerts and filters that match your business — never miss a relevant opportunity again.

See plans

Key Details

Submission Deadline
Mar 11, 2026
Deadline passed
Estimated Budget
UAH 4,024,000 - UAH 4,024,000
Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
uk

Source

prozorro_ua
prozorro_ua
Official Source

Contracting Authority

Військово-медичний клінічний центр Центрального регіону
🇺🇦Ukraine

Matching Experts

Are you a consultant?

Join our Expert Network and get matched with relevant tenders.